BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ConforMIS Files for Interference Proceeding Against Imperial Innovations Group


3/22/2012 6:27:27 AM

BURLINGTON, Mass.--(BUSINESS WIRE)--ConforMIS, Inc. filed documents to initiate an interference proceeding in the United States Patent and Trademark Office involving a patent application held by Imperial Innovations Group. The subject patent application, US 2011/0218635A1 entitled “Modular Knee Implants,” lists Andrew Amis, Robert Wozencroft, and Justin Cobb as inventors. Imperial Innovations Group, an entity associated with the Imperial College London, recently announced a license of patented technology to Stanmore Implants in addition to a £4 million investment in the company to develop that technology, including the patient-specific Savile Row Unicondylar Knee implant.

Read at BioSpace.com


ConforMIS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->